SILO PHARMA, INC. Current Liabilities
SILO PHARMA, INC. (SILO) had Current Liabilities of $1.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $1.07M.
- 2026-03-31: Liabilities, Current $704.85K.
- 2025-12-31: Liabilities, Current $650.18K.
- 2025-09-30: Liabilities, Current $708.34K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $704.85K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $650.18K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $708.34K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.05M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.19M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.66M POS AM · filed 2026-04-14 |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.32M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $873.67K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $775.59K 10-K · filed 2025-03-28 |
| 2023-09-30 | $678.77K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.12M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $732.38K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $436.32K 10-K · filed 2024-03-25 |
| 2022-09-30 | $312.19K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $268.85K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $292.75K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $490.04K 10-K · filed 2023-03-24 |
| 2021-09-30 | $283.39K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $264.13K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $326.99K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $141.72K 10-K · filed 2022-03-28 |
| 2020-09-30 | $122.03K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $80.05K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $265.59K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $116.74K 10-K/A · filed 2021-05-17 |
| 2019-09-30 | $87.83K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $32.59K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $58.19K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $47.98K 10-K · filed 2020-03-20 |
| 2018-09-30 | $28.73K 10-Q · filed 2018-11-14 |
| 2017-12-31 | $38.34K 10-K · filed 2019-04-04 |
| 2013-09-30 | $715.48K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $35.23K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $54.17K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $25.69K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $14.28K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $6.27K 10-Q · filed 2012-08-01 |
| 2012-03-31 | $3.50K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $3.50K 10-K · filed 2013-03-05 |
| 2011-06-30 | $3.50K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |